Advertisement
Oncology
Subscribe to Oncology
View Sample

FREE Email Newsletter

Cancer Research Implies Future for Personalized Medicine

August 7, 2013 11:24 am | by The Journal of Visualized Experiments | News | Comments

The Journal of Visualized Experiments has published two new methods for scientists to study and treat tumor growth. The methods introduce a lab-born, human tissue structure with replicated human biochemistry – offering scientists the opportunity to grow, observe, and ultimately learn how to treat biopsied human tumor cells.

Commonly Used Catheter's Safety Tied to Patient Population

August 6, 2013 12:11 pm | by Society for Healthcare Epidemiology of America | News | Comments

A new study reports that peripherally inserted central catheters (PICCs) do not reduce the risk of central line associated bloodstream infections (CLABSIs) in hospitalized patients. PICCs have become one of the most commonly used central venous catheters (CVCs) in healthcare settings since they are considered easier and safer to use, with less risk of CLABSIs.

Catching Cancer Early by Chasing It

August 5, 2013 11:01 am | by American Institute of Physics | News | Comments

Reaching a clinic in time to receive an early diagnosis for cancer -- when the disease is most treatable -- is a global problem. And now a team of Chinese researchers proposes a global solution: have a user-friendly diagnostic device travel to the patient, anywhere in the world.

Advertisement

Camera Crushes Patient; Sparks Recall

August 1, 2013 12:40 pm | by David Mantey, Executive Editor, MDT | News | Comments

This week, the U.S. Food and Drug Administration (FDA) announced the recall of GE Healthcare’s Nuclear Medicine Systems were recalled following an incident at a VA Medical Center in which a patient died due to injuries sustained while being scanned.

3D Colonoscopy Eases Detection of Precancerous Lesions

August 1, 2013 10:29 am | by Massachusetts Institute of Technology | News | Comments

MIT researchers have developed a new endoscopy technology that could make it easier for doctors to detect precancerous lesions in the colon. Early detection of such lesions has been shown to reduce death rates from colorectal cancer, which kills about 50,000 people per year in the United States.

Panel Backs Lung Cancer Screening for Some Smokers

July 30, 2013 12:54 pm | by Marilynn Marchione, AP Chief Medical Writer | News | Comments

For the first time, government advisers are recommending screening for lung cancer, saying certain current and former heavy smokers should get annual scans to cut their chances of dying of the disease. If it becomes final as expected, the advice by the U.S. Preventive Services Task Force would clear the way for insurers to cover CT scans, a type of X-ray, for those at greatest risk.

GE Healthcare Submits the Final Module of Its Premarket Approval Application (PMA) for GE Breast Tomosynthesis Option

July 30, 2013 9:00 am | by Business Wire | News | Comments

GE Healthcare, a unit of General Electric Company (NYSE:GE), announced that it recently submitted to the U.S. Food and Drug Administration (FDA) the final module of its premarket approval application (PMA1) for GE Breast Tomosynthesis, an option of the Senographe Essential system.

University Researches Effectiveness of Telehealth

July 29, 2013 11:27 am | by University of Salford | News | Comments

The University of Salford has carried out a systematic review of the literature to research the effectiveness of telehealth on clinical outcomes, cost effectiveness and patient experience. Telehealth allows patients to monitor long-term health conditions from home, reducing visits to a clinic or hospital.

Advertisement

Breakthrough in Detecting DNA Mutations Could Help Treat Tuberculosis, Cancer

July 29, 2013 10:24 am | by University of Washington | News | Comments

Modern genomics has shown that just one mutation can be the difference between successfully treating a disease and having it spread rampantly throughout the body. Now, researchers have developed a new method that can look at a specific segment of DNA and pinpoint a single mutation, which could help diagnose and treat diseases such as cancer and tuberculosis.

RainDrop System Unlocks Power of Trovagene's Urine-Based Mutation Detection Technology

July 29, 2013 5:00 am | by PR Newswire | News | Comments

Trovagene, Inc. (NASDAQ: TROV) and RainDance Technologies announced today that Trovagene has adopted RainDance's RainDropTM Digital PCR System for research and development, and for eventual use in the Trovagene CLIA laboratory.  Trovagene has also announced successful development of a cell-free DNA mutation assay leveraging the RainDrop platform.

Study in British Journal of Urology International Features a Practical Solution for MRI-Ultrasound Fusion to Enable Tumor-Targeted, Tissue-Preserving Prostate HIFU Treatment

July 25, 2013 2:16 pm | by The Associated Press | News | Comments

Study results published in the current issue of British Journal of Urology International (10.1111/bju.12223) demonstrate that new software to register and fuse information from magnetic resonance imaging (MRI) and ultrasound (US) images enables intraoperative visualization of tumors, not ordinarily seen in a US image.

Women’s Height Linked to Cancer Risk

July 25, 2013 1:00 pm | by AACR | News | Comments

The taller a postmenopausal woman is, the greater her risk for developing cancer, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. Height was linked to cancers of the breast, colon, endometrium, kidney, ovary, rectum, and thyroid, as well as to multiple myeloma and melanoma...  

A Promising Test for Pancreatic Cancer ... From a Teenager

July 25, 2013 10:12 am | Videos | Comments

Over 85 percent of all pancreatic cancers are diagnosed late, when someone has less than two percent chance of survival. How could this be? Jack Andraka talks about how he developed a promising early detection test for pancreatic cancer that’s super cheap, effective and non-invasive -- all before his 16th birthday.

Advertisement

Researchers Develop New Approach for Studying Deadly Brain Cancer

July 24, 2013 11:40 am | by University Of Illinois | News | Comments

A team of engineers has developed a three-dimensional hydrogel that more closely mimics conditions in the brain. In a paper in the journal Biomaterials, the researchers describe the new material and their approach, which allows them to selectively tune up or down the malignancy of the cancer cells they study.

‘Standards’ for Home Healthcare

July 23, 2013 4:44 pm | by Todd Konieczny, Assistant Chief Engineer, Americas Region; Technical Manager, Medical Division, Intertek | Blogs | Comments

The following standard must be met for all medical products intended to be used in the home: IEC 60601-1-11, which is “Medical Electrical Equipment—Part 1-11: General Requirements for Basic Safety and Essential Performance—Collateral Standard: Requirements for Medical Electrical Equipment and Medical Electrical Systems Used in the Home Healthcare Environment.”

Researchers Put Squeeze on Cells to Deliver

July 23, 2013 11:12 am | by National Institute of Biomedical Imaging and Bioengineering | News | Comments

Imagine being able to redirect powerful immune cells to fight cancer. How about reprogramming a diabetic’s skin cell into a cell that could manufacture the insulin their pancreas no longer produces? These are major health problems and medical challenges that may be more achievable with a new fundamental technology that gets vital control molecules into cells faster, safer, and more effectively.

Urine-based Cancer Detection Technology Validated

July 22, 2013 5:00 am | by The Associated Press | News | Comments

Trovagene, Inc. announces that results emerging from ongoing clinical studies have confirmed the broad applicability of Trovagene technology across a variety of cancer types, and the successful development of a molecular diagnostic test capable of detecting and quantifying oncogene mutations from a simple urine specimen.

Cold Caps Tested To Prevent Hair Loss from Chemotherapy

July 22, 2013 3:27 am | by Lauran Neergaard, Associated Press | News | Comments

The first time Miriam Lipton had breast cancer, her thick locks fell out two weeks after starting chemotherapy. The second time breast cancer struck, Lipton gave her scalp a deep chill and kept much of her hair — making her fight for survival seem a bit easier.

New Surgical Knife Can Instantly Detect Cancer

July 17, 2013 2:34 pm | by Maria Cheng - AP Medical Writer - Associated Press | News | Comments

An experimental surgical knife can help surgeons make sure they've removed all the cancerous tissue, doctors reported Wednesday. Surgeons typically use knives that heat tissue as they cut, producing a sharp-smelling smoke. The new knife analyzes the smoke and can instantly signal whether the tissue is cancerous or healthy.

Nordion sells targeted therapy biz for $200M

July 17, 2013 10:29 am | by Mass Device | News | Comments

Ottawa-based Nordion unloaded its targeted therapy business, handing the division, related products and about 40 employees over to British life sciences company BTG plc for $200 million. BTG will take over the division's lone product, an increasingly lucrative targeted liver cancer therapy system called TheraSphere.

CSI-Style DNA Fingerprinting Tracks Down Cause of Cancer Spread

July 16, 2013 11:35 am | by Garth Sundem, University of Colorado Cancer Center | News | Comments

The University of Colorado Cancer Center along with Yale University and the Denver Crime Lab report in the journal PLoS ONE the first proof of cancer’s ability to fuse with blood cells in a way that gives cancer the ability to travel, allowing previously stationary cancer cells to enter the bloodstream and seed sites of metastasis around the body.

Froedtert & The Medical College of Wisconsin Clinical Cancer Center Joins Elekta and Philips Research Consortium on MRI-Guided Radiation Therapy

July 16, 2013 9:00 am | by PR Newswire | News | Comments

Elekta (NSE: EKTAb) and Royal Philips (NYSE: PHG, AEX: PHIA) announced today that the Froedtert & The Medical College of Wisconsin Clinical Cancer Center (Milwaukee, Wisconsin) will join a consortium that is investigating the development of a magnetic resonance imaging (MRI) guided radiation therapy system.

Finding Cancer Cells in the Blood

July 16, 2013 12:00 am | by Massachusetts Institute of Technology | News | Comments

In the near future, oncologists may be using a finger-size plastic chip with tiny channels to extract a dozen or so cancer cells from a sample of a patient’s blood. Those cells, called circulating tumor cells, could then be screened for genetic disruptions that an oncologist could target with drugs best suited to attacking the tumor.

Commercial Release of 3D (Breast Tomosynthesis) Biopsy Option Strengthens Hologic's Position as Provider of the Nation's Most Comprehensive Portfolio of Interventional Breast Health Solutions

July 15, 2013 4:15 pm | by PR Newswire | News | Comments

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, recently expanded its extensive array of interventional and imaging solutions for breast health with the launch of the world's first 3D breast biopsy option.

York Physicists Offer Novel Insight into Experimental Cancer Treatment

July 15, 2013 12:50 pm | by University of York | News | Comments

Magnetic hyperthermia is viewed as an attractive approach for the treatment of certain cancers as it has no known side effects compared to more conventional therapies such as chemotherapy. It is particularly suitable for the treatment of prostate cancer and brain tumors. However, until now there has been no clear theoretical understanding of how it actually works.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading